Form 4: Elevance Health Director Robert L. Dixon Jr. Reports Acquisition of Deferred Stock Units

Director Robert L. Dixon Jr. reports acquiring 601 deferred stock units of Elevance Health, Inc.

Summary

• Robert L. Dixon Jr., a director of Elevance Health, Inc., reported a transaction on May 14, 2025.
• He acquired 601 deferred stock units under the company's Board of Directors Compensation Program.
• These units will be payable in Elevance Health common stock either five years from the grant date or upon ceasing to be a board member, unless a later date is designated.
• Following the transaction, Dixon beneficially owns 10,322 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock ownership, and does not contain information that would significantly impact sentiment.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and ownership.

Key Dates

Keywords

Elevance Health, Director, Robert L. Dixon Jr., Deferred Stock Units, Beneficial Ownership, Form 4, ELV, Compensation Program